Revenue: The sum of all revenue fields included for a company's operating activities.
Fate Therapeutics, Inc. (FATE) had Revenue of $1.63M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$1.63M |
$-37.62M |
|
-- |
|
$1.63M |
|
$42.91M |
|
$-41.28M |
|
$3.66M |
|
$-37.62M |
|
$-37.62M |
|
$-37.62M |
|
$-37.62M |
|
$-37.62M |
|
$-37.62M |
|
$-41.28M |
|
$-39.02M |
|
118.38M |
|
118.38M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$248.22M |
|
$62.76M |
|
$150.45M |
|
$398.67M |
|
$28.16M |
|
-- |
|
$82.10M |
|
$110.26M |
|
$288.41M |
|
$288.41M |
|
$288.41M |
|
114.60M |
|
| Cash Flow Statement Financials | |
$-33.81M |
|
$42.67M |
|
-- |
|
$46.28M |
|
$55.15M |
|
$8.86M |
|
$7.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2534.07% |
|
-2534.07% |
|
-- |
|
-2309.45% |
|
-2309.45% |
|
$-35.01M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.68 |
|
132.93 |
|
-13.04% |
|
-13.04% |
|
-9.44% |
|
-13.04% |
|
$2.52 |
|
$-0.30 |
|
$-0.29 |
|